Articles related to BRAIN INJURY/CONCUSSION

The multidisciplinary guidelines introduce blood-based biomarkers as key diagnostic tools, potentially reducing unnecessary CT scans while improving outcome predictions.

Amantadine emerges as the pharmacologic agent with the most support for improving cognitive impairment after TBI, while cognitive rehabilitation interventions demonstrate substantial evidence for enhancing neurocognitive function and reducing functional limitations.

Dr. Mathew Rolando’s tragic incident while scuba diving underlines the critical importance of recognizing and promptly treating decompression sickness and other dive-related emergencies to mitigate fatal outcomes.

In recent research, elevated levels of a brain repair protein were found in former NFL athletes, suggesting ongoing inflammation and repair years after their careers. This highlights the need for continued monitoring and research into treatments for traumatic brain injuries.

A Maryland family was awarded almost $34 million after an unnecessary emergency C-section led to brain damage in their infant. This case serves as a stark reminder of the potential consequences of medical decisions and the importance of effective communication within healthcare teams.

The introduction of these new guidelines marks a significant advancement in our understanding and determination of brain death. An emphasis on standardization and accuracy, these guidelines could change how we approach this critical aspect of medical practice.